The More, The Better: “Do the Right Thing” For Natural Killer Immunotherapy in Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The More, The Better: “Do the Right Thing” For Natural Killer Immunotherapy in Acute Myeloid Leukemia

Published:2017-10-19 Issue: Volume:8 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Parisi Sarah,Lecciso Mariangela,Ocadlikova Darina,Salvestrini Valentina,Ciciarello Marilena,Forte Dorian,Corradi Giulia,Cavo Michele,Curti Antonio

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference60 articles.

1. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Döhner;Blood,2017

2. Acute myeloid leukemia;Döhner;N Engl J Med,2015

3. Genomics of acute myeloid leukemia diagnosis and pathways;Bullinger;J Clin Oncol,2017

4. Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for “prime time”?;Grimwade;Blood,2014

5. Current strategies in immunotherapy for acute myeloid leukemia;Lichtenegger;Immunotherapy,2013

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel therapeutic strategy: the significance of exosomal miRNAs in acute myeloid leukemia;Medical Oncology;2024-01-23

2. Editorial: Translating NK cell scientific research to clinical product manufacturing;Frontiers in Immunology;2023-08-23

3. Recent advances in the roles of exosomal microRNAs (exomiRs) in hematologic neoplasms: pathogenesis, diagnosis, and treatment;Cell Communication and Signaling;2023-05-01

4. Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire;Frontiers in Immunology;2023-02-14

5. Phenotypic and functional characterisation of locally produced natural killer cells ex vivo expanded with the K562-41BBL-mbIL21 cell line;Clinical and Experimental Medicine;2022-12-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3